Related Experiment Video

Updated: Jun 21, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Pneumocystis jiroveci: epidemiological, pathophysiological and biological update]

S Vedy1, C Ragot, Y Robet

  • 1Fédération des laboratoires, Hôpital d'instruction des armées Legouest, Metz Armées. vedy.serge@wanadoo.fr

Annales De Biologie Clinique
|August 6, 2009
PubMed

Insights

Pneumocystis jiroveci pneumonia (PJP) remains a significant threat to immunocompromised patients. Advances in molecular biology have improved understanding and diagnosis, necessitating an updated laboratory strategy.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Pneumocystis jiroveci is an opportunistic fungal pathogen.
  • It causes severe pneumonia, particularly in immunocompromised individuals.
  • High mortality rates persist despite advances in treatment.

Purpose of the Study:

  • To synthesize current knowledge on Pneumocystis jiroveci.
  • To review molecular biology advancements in its diagnosis.
  • To update laboratory diagnosis strategies for Pneumocystis pneumonia.

Main Methods:

  • Literature review of molecular biology techniques.
  • Analysis of diagnostic methods for Pneumocystis jiroveci.
  • Synthesis of epidemiological and pathophysiological data.

Main Results:

  • Molecular biology has significantly advanced the understanding of Pneumocystis jiroveci epidemiology and pathophysiology.
  • Numerous molecular diagnostic methods have been published.
  • Current diagnostic approaches vary widely.

Conclusions:

  • An updated laboratory diagnosis strategy is crucial for managing Pneumocystis pneumonia.
  • Integrating molecular techniques can improve diagnostic accuracy and patient outcomes.
  • Continued research is needed to refine diagnostic protocols.

More Related Videos

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...